Key result
In-frame SCN8A variants can lead to increased seizure susceptibility in mouse models and neurodevelopmental phenotypes without seizures in human patients, expanding the genetic landscape of SCN8A-associated disease.
Why the study?
Only a few Scn8a mouse models had in-frame deletions or insertions, and none had exhibited increased seizure susceptibility.
In-frame deletions in the SCN8A gene increase seizure susceptibility and cause spontaneous seizures in mouse models, highlighting the pathogenic potential of this class of mutations in SCN8A-associated neurodevelopmental and epileptic disorders.
Answers are grounded in this paper and cite their sources.
May broaden SCN8A testing in neurodevelopmental disorders; leaves open human pathogenicity confirmation.
Numerous SCN8A mutations have been identified, of which, the majority are de novo missense variants. Most mutations result in epileptic encephalopathy; however, some are associated with less severe phenotypes. Mouse models generated by knock-in of human missense SCN8A mutations exhibit seizures and a range of behavioral abnormalities. To date, there are only a few Scn8a mouse models with in-frame deletions or insertions, and notably, none of these mouse lines exhibit increased seizure susceptibility. In the current study, we report the generation and characterization of two Scn8a mouse models (ΔIRL/+ and ΔVIR/+) carrying overlapping in-frame deletions within the voltage sensor of domain 4 (DIVS4). Both mouse lines show increased seizure susceptibility and infrequent spontaneous seizures. We also describe two unrelated patients with the same in-frame SCN8A deletion in the DIV S5-S6 pore region, highlighting the clinical relevance of this class of mutations.
No takes yet. Share an insight, caveat, or question.
Wong et al. (2021) studied SCN8A-associated disease (n=2). In-frame SCN8A variants vs. Wild-type was evaluated on Phenotypic presentation (seizures and neurodevelopmental deficits). In-frame SCN8A variants can lead to increased seizure susceptibility in mouse models and neurodevelopmental phenotypes without seizures in human patients, expanding the genetic landscape of SCN8A-associated disease.
Synapse has enriched 10 related papers. Consider them for comparative context: